RB Capital Management LLC Sells 798 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• RB Capital Management LLC reduced its holdings in UnitedHealth Group by 14.8%, selling 798 shares, which brings its total to 4,584 shares valued at approximately $1.43 million.
• UnitedHealth Group reported earnings per share of $4.08 for the recent quarter, missing analyst expectations of $4.45 and showing a revenue of $111.62 billion, which was slightly below estimates.
• The company announced a quarterly dividend of $2.21, with an annualized payout of $8.84, representing a yield of 2.5% and a payout ratio of 38.30%.

RB Capital Management LLC lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 14.8% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,584 shares of the healthcare conglomerate's stock after selling 798 shares during the quarter. RB Capital Management LLC's holdings in UnitedHealth Group were worth $1,430,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Bayforest Capital Ltd grew its stake in UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after purchasing an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd grew its stake in UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after purchasing an additional 50 shares during the period. Copia Wealth Management purchased a new stake in UnitedHealth Group in the fourth quarter worth $42,000. IAG Wealth Partners LLC purchased a new stake in UnitedHealth Group in the first quarter worth $42,000. Finally, Investment Management Corp VA ADV purchased a new stake in UnitedHealth Group in the fourth quarter worth $44,000. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Down 0.3%

UNH stock opened at $352.61 on Friday. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The business's 50-day moving average is $291.98 and its two-hundred day moving average is $369.01. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The company has a market cap of $319.35 billion, a price-to-earnings ratio of 15.28, a P/E/G ratio of 2.31 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same period in the prior year, the company posted $6.80 EPS. The firm's revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a $2.21 dividend. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group's dividend payout ratio is currently 38.30%.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the company. Wolfe Research reduced their price target on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a research note on Tuesday, May 20th. Morgan Stanley boosted their target price on UnitedHealth Group from $325.00 to $395.00 and gave the stock an "overweight" rating in a report on Friday. Hsbc Global Res downgraded UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a report on Wednesday, May 21st. Piper Sandler dropped their target price on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. Finally, KeyCorp lowered their price target on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. Sixteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $358.95.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.